← All organizations

Agile Therapeutics

For profitWebsite ↗

Also known as: AGILE

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Feb 14, 2020

Timeline

1990s

Jun 1, 1997
Agile Therapeutics— Founded

2020s

Feb 14, 2020
norgestrel— NDA Secondary Org

Drugs by trial phase (3 distinct, 8 trials)

Phase 3 (3 own, 0 via acquisition)

Indications

Studied for

Vision Disorders

Marketed drugs (2)

Recent trials (13)

NCT02158572Lead sponsorPhase 3Jul 1, 2014
NCT01623466Study directorPhase 1/Phase 2Jun 1, 2012
NCT01623466Lead sponsorPhase 1/Phase 2Jun 1, 2012
NCT01375946Lead sponsorPhase 1May 1, 2011
NCT01422135Study directorPhase 1Feb 1, 2011
NCT01422135Lead sponsorPhase 1Feb 1, 2011
NCT01236768Lead sponsorPhase 3Oct 1, 2010
NCT01236768Study directorPhase 3Oct 1, 2010
NCT01181479Study directorPhase 3Aug 1, 2010
NCT01181479Lead sponsorPhase 3Aug 1, 2010
NCT01243580Study directorPhase 1Aug 1, 2009
NCT01243580Lead sponsorPhase 1Aug 1, 2009
NCT01250210Lead sponsorPhase 2Sep 1, 2007

Details

Founded: Princeton, New Jersey, US Jun 1, 1997
Last known activity: Feb 14, 2020